Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity, Common Stock Purchase Warrants (Details Narrative)

v3.21.1
Stockholders' Equity, Common Stock Purchase Warrants (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended
Jan. 05, 2021
May 14, 2021
Feb. 23, 2021
Jan. 31, 2021
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Common shares authorized         150,000,000   150,000,000
Common stock, par value per share         $ 0.001   $ 0.001
Common stock, shares issued         81,424,744   63,819,935
Common stock, shares outstanding         81,424,744   63,819,935
Gross proceeds from issuance of common stock         $ 55,016  
Warrants were exercised price per share         $ 1.68   $ 1.57
Repayment of convertible debt         $ 14,816  
Periodic payment interest         11,511    
Number of stock option exercised         $ 80    
2014 Equity Plan [Member] | Stock Option [Member]              
Number of stock option exercised, shares         80,000    
Number of stock option exercised         $ 80    
PAVmed Inc. Employee Stock Purchase Plan [Member] | Employees [Member]              
Number of stock option exercised, shares         203,480    
November 2019 Senior Convertible Notes [Member]              
Debt conversion share issued       667,668      
Repayment of convertible debt       $ 956      
Periodic payment interest       $ 7      
Series Z Warrants [Member]              
Number of common stock shares issued         860,217    
Warrants were exercised price per share         $ 1.60    
Series Z Warrants [Member] | Subsequent Event [Member]              
Number of common stock shares issued   672,954          
Warrants were exercised price per share   $ 1.60          
Series B Convertible Preferred Stock [Member]              
Debt conversion share issued         10,835    
Series S Warrants [Member]              
Warrants were exercised price per share         $ 0.01    
Warrants exercised         1,199,383    
Common Stock [Member]              
Number of common stock shares issued 6,000,000   9,782,609        
Gross proceeds from issuance of common stock $ 13,434   $ 41,566        
Placement agent fees and legal fees 951            
Offering cost $ 71   $ 290        
Number of stock option exercised, shares         80,000    
Number of stock option exercised